Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure.

Nieminen MS, Fonseca C, Brito D, Wikström G.

Eur Heart J Suppl. 2017 Mar;19(Suppl C):C15-C21. doi: 10.1093/eurheartj/sux003. Epub 2017 Mar 8.

2.

CXL-1020, a Novel Nitroxyl (HNO) Prodrug, Is More Effective than Milrinone in Models of Diastolic Dysfunction-A Cardiovascular Therapeutic: An Efficacy and Safety Study in the Rat.

Roof SR, Ueyama Y, Mazhari R, Hamlin RL, Hartman JC, Ziolo MT, Reardon JE, Del Rio CL.

Front Physiol. 2017 Nov 10;8:894. doi: 10.3389/fphys.2017.00894. eCollection 2017.

3.

The Perspective of the Intensivist on Inotropes and Postoperative Care Following Pediatric Heart Surgery: An International Survey and Systematic Review of the Literature.

Roeleveld PP, de Klerk JCA.

World J Pediatr Congenit Heart Surg. 2018 Jan;9(1):10-21. doi: 10.1177/2150135117731725. Epub 2017 Nov 1.

4.

Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.

Kim MS, Lee JH, Kim EJ, Park DG, Park SJ, Park JJ, Shin MS, Yoo BS, Youn JC, Lee SE, Ihm SH, Jang SY, Jo SH, Cho JY, Cho HJ, Choi S, Choi JO, Han SW, Hwang KK, Jeon ES, Cho MC, Chae SC, Choi DJ.

Korean Circ J. 2017 Sep;47(5):555-643. doi: 10.4070/kcj.2017.0009. Epub 2017 Sep 18. Review.

5.

Management of pulmonary hypertension from left heart disease in candidates for orthotopic heart transplantation.

Koulova A, Gass AL, Patibandla S, Gupta CA, Aronow WS, Lanier GM.

J Thorac Dis. 2017 Aug;9(8):2640-2649. doi: 10.21037/jtd.2017.07.24. Review.

6.

Update of treatment of heart failure with reduction of left ventricular ejection fraction.

Aronow WS.

Arch Med Sci Atheroscler Dis. 2016 Oct 17;1(1):e106-e116. doi: 10.5114/amsad.2016.63002. eCollection 2016.

7.

Reverse translation of adverse event reports paves the way for de-risking preclinical off-targets.

Maciejewski M, Lounkine E, Whitebread S, Farmer P, DuMouchel W, Shoichet BK, Urban L.

Elife. 2017 Aug 8;6. pii: e25818. doi: 10.7554/eLife.25818.

8.

Quality of life and long-term mortality in patients with advanced chronic heart failure treated with intermittent low-dose intravenous inotropes in an outpatient setting.

Chernomordik F, Freimark D, Arad M, Shechter M, Matetzky S, Savir Y, Shlomo N, Peled A, Goldenberg I, Peled Y.

ESC Heart Fail. 2017 May;4(2):122-129. doi: 10.1002/ehf2.12114. Epub 2016 Sep 17.

9.

FRET biosensor uncovers cAMP nano-domains at β-adrenergic targets that dictate precise tuning of cardiac contractility.

Surdo NC, Berrera M, Koschinski A, Brescia M, Machado MR, Carr C, Wright P, Gorelik J, Morotti S, Grandi E, Bers DM, Pantano S, Zaccolo M.

Nat Commun. 2017 Apr 20;8:15031. doi: 10.1038/ncomms15031.

10.

Resveratrol enhances the inotropic effect but inhibits the proarrhythmic effect of sympathomimetic agents in rat myocardium.

Hernandez-Cascales J.

PeerJ. 2017 Mar 30;5:e3113. doi: 10.7717/peerj.3113. eCollection 2017.

11.

Perioperative Inotrope Therapy and Atrial Fibrillation Following Coronary Artery Bypass Graft Surgery: Evidence of a Racial Disparity.

Efird JT, Kiser AC, Crane PB, Landrine H, Kindell LC, Nelson MA, Jindal C, Sarpong DF, Griffin WF, Ferguson TB, Chitwood WR, Davies SW, Kypson AP, Gudimella P, Anderson EJ.

Pharmacotherapy. 2017 Mar;37(3):297-304. doi: 10.1002/phar.1894. Epub 2017 Feb 3.

12.

Pharmacological evidence: a new therapeutic approach to the treatment of chronic heart failure through SUR2B/Kir6.1 channel in endothelial cells.

Wang S, Long CL, Chen J, Cui WY, Zhang YF, Zhang H, Wang H.

Acta Pharmacol Sin. 2017 Jan;38(1):41-55. doi: 10.1038/aps.2016.118. Epub 2016 Nov 28.

13.

Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease.

Kim GE, Kass DA.

Handb Exp Pharmacol. 2017;243:249-269. doi: 10.1007/164_2016_82. Review.

14.

Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction : Study protocol for a randomized controlled trial.

Mascherbauer J, Grünig E, Halank M, Hohenforst-Schmidt W, Kammerlander AA, Pretsch I, Steringer-Mascherbauer R, Ulrich S, Lang IM, Wargenau M, Frey R, Bonderman D.

Wien Klin Wochenschr. 2016 Dec;128(23-24):882-889. Epub 2016 Sep 2.

15.

Novel role of phosphodiesterase inhibitors in the management of end-stage heart failure.

Jaiswal A, Nguyen VQ, Le Jemtel TH, Ferdinand KC.

World J Cardiol. 2016 Jul 26;8(7):401-12. doi: 10.4330/wjc.v8.i7.401. Review.

16.

Cardiac Adenylyl Cyclase and Phosphodiesterase Expression Profiles Vary by Age, Disease, and Chronic Phosphodiesterase Inhibitor Treatment.

Nakano SJ, Sucharov J, van Dusen R, Cecil M, Nunley K, Wickers S, Karimpur-Fard A, Stauffer BL, Miyamoto SD, Sucharov CC.

J Card Fail. 2017 Jan;23(1):72-80. doi: 10.1016/j.cardfail.2016.07.429. Epub 2016 Jul 15.

17.

Positive inotropes in heart failure: a review article.

Amin A, Maleki M.

Heart Asia. 2012 Jan 1;4(1):16-22. doi: 10.1136/heartasia-2011-010068. eCollection 2012.

18.

The Effect of Cilostazol on Endothelial Function as Assessed by Flow-Mediated Dilation in Patients with Coronary Artery Disease.

Mori H, Maeda A, Wakabayashi K, Sato T, Sasai M, Tashiro K, Iso Y, Ebato M, Suzuki H.

J Atheroscler Thromb. 2016 Oct 1;23(10):1168-1177. Epub 2016 May 9.

19.

Inotropic agents use in patients hospitalized with acute decompensated heart failure: a retrospective analysis from a 22-year registry in a Middle-Eastern Country (1991-2013).

Aljundi AHS, Mohammed SFK, Patel A, Singh R, Arabi A, AlBinali HA, Al Suwaidi J.

BMC Cardiovasc Disord. 2016 Feb 19;16:47. doi: 10.1186/s12872-016-0223-5.

20.

Novel Perspectives in Redox Biology and Pathophysiology of Failing Myocytes: Modulation of the Intramyocardial Redox Milieu for Therapeutic Interventions-A Review Article from the Working Group of Cardiac Cell Biology, Italian Society of Cardiology.

Arcaro A, Pirozzi F, Angelini A, Chimenti C, Crotti L, Giordano C, Mancardi D, Torella D, Tocchetti CG.

Oxid Med Cell Longev. 2016;2016:6353469. doi: 10.1155/2016/6353469. Epub 2016 Jan 5. Review.

Supplemental Content

Support Center